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Abstract
Disruptive mood dysregulation disorder (DMDD) involves non-episodic irritability and frequent severe temper outbursts 
in children. Since the inclusion of the diagnosis in the DSM-5, there is no established gold-standard in the assessment of 
DMDD. In this systematic review of the literature, we provide a synopsis of existing diagnostic instruments for DMDD. 
Bibliographic databases were searched for any studies assessing DMDD. The systematic search of the literature yielded 
K = 1167 hits, of which n = 110 studies were included. The most frequently used measure was the Kiddie Schedule for 
Affective Disorders and Schizophrenia DMDD module (25%). Other studies derived diagnostic criteria from interviews not 
specifically designed to measure DMDD (47%), chart review (7%), clinical diagnosis without any specific instrument (6%) or 
did not provide information about the assessment (9%). Three structured interviews designed to diagnose DMDD were used 
in six studies (6%). Interrater reliability was reported in 36% of studies (ranging from κ = 0.6–1) while other psychometric 
properties were rarely reported. This systematic review points to a variety of existing diagnostic measures for DMDD with 
good reliability. Consistent reporting of psychometric properties of recently developed DMDD interviews, as well as their 
further refinement, may help to ascertain the validity of the diagnosis.
Keywords Disruptive mood dysregulation disorder · Irritability · Diagnostics · Measurement · Systematic review of the 
literature
Introduction
Disruptive mood dysregulation disorder (DMDD) is a 
relatively new diagnosis, which has been introduced to 
the domain of depressive disorders in the fifth version of 
the Diagnostic and Statistical Manual of Mental Disor-
ders (DSM-5) in 2013 [1]. The diagnosis was endorsed by 
DSM-5 work groups to address concerns that children with 
pathological irritability and temper outbursts/anger were 
being inappropriately diagnosed with bipolar disorder [2]. 
The diagnosis of bipolar disorder did not accurately capture 
the non-episodic nature of those children’s symptoms and 
therefore, might have led to questionable treatment decisions 
[3]. The development of the DMDD diagnosis was based on 
the description of a broad phenotype of pediatric bipolar dis-
order called severe mood dysregulation (SMD) by Leiben-
luft and colleagues in 2003 [4]. In addition to irritability and 
anger, the latter required symptoms of chronic hyperarousal 
(e.g. agitation, distractibility, racing thoughts, insomnia, 
pressured speech or intrusiveness). Increasing evidence of 
the clinical distinction between episodic and non-episodic 
irritability and anger as well as distinct pathophysiology 
finally led to the formulation of the new diagnosis [2, 5–7].
DMDD involves non-episodic anger or irritability and 
frequent severe temper outbursts over a period of at least 
one year in pediatric patients aged 6–18 years [1]. Temper 
outbursts occur on average three or more times per week, 
can occur verbally or behaviorally (e.g. physical aggres-
sion towards objects or persons), their duration or intensity 
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is inappropriate to the situation and they are inconsistent 
with the child’s developmental level. DMDD is charac-
terized by persistent irritable and angry mood between 
temper outbursts in at least two of three settings (i.e. at 
home, at school, with peers). While the average age of 
onset is suggested to be 5 years of age [2], the diagnosis 
is assigned from age 6, as the identification of pathology 
before this age is difficult due to normal variations in pre-
school behavior [8].
The prevalence of DMDD ranges from 0.8% to 3.3%, with 
2–3% in preschool children, 1–3% in 9–12 year-olds, and 
0–0.12% in adolescents [9–11]. Although the prevalence of 
DMDD decreases with increasing age, individuals with a 
history of DMDD are at higher risk for adult depression 
and anxiety, adverse health outcomes, low educational 
attainment, poverty, and reported police contact, compared 
to healthy and clinical controls with other psychiatric con-
ditions [11]. Prevalence estimates differ between studies 
because there is substantial diagnostic variability in the 
adherence to DSM-5 criteria with respect to the frequency of 
outbursts, the duration of irritability or the exclusion criteria.
Comorbidity is one of the obstacles which have been 
reported around the DMDD diagnosis [12]. The majority 
of patients with DMDD have at least one other comorbid 
psychiatric disorder, of which oppositional defiant disorder 
(ODD) or depressive disorders are most commonly reported 
[10]. In addition, there is substantial diagnostic overlap with 
childhood psychiatric disorders such as ODD, intermittent 
explosive disorder or attention deficit hyperactivity disorder 
(ADHD), questioning the validity of the diagnosis as a dis-
tinct disorder [13–15]. Correspondingly, in the International 
Classification of Diseases and Related Health Problems 
(ICD‐11), DMDD will be listed as a subtype “with chronic 
irritability‐anger” of oppositional defiant disorder [16].
The diagnostic challenges may, at least in part, be due 
to difficulties in its assessment [17]. As such, symptoms of 
DMDD are not unique to children referred for psychiatric 
services. Hence, many existing measures provide ques-
tions which assess symptoms relevant to DMDD (e.g. irri-
tability is measured but considered a nonspecific indicator 
and is related to several other psychiatric disorders) [12]. 
Moreover, structured interviews or questionnaires specifi-
cally developed to diagnose DMDD are still in their infancy. 
Consequently, there is currently no gold standard or broad 
consensus regarding the clinical assessment of DMDD.
In this systematic review of the literature, we aimed to 
provide a synopsis of all measures that have been used in 
diagnosing DMDD since the advent of the diagnosis in 
2013. Study characteristics of the included studies, quanti-
ties of used diagnostic measures, and psychometric prop-
erties, where applicable, are reported and discussed. The 
results of this systematic review of the literature might guide 
future research in the selection of appropriate tools to diag-
nose DMDD in the clinical and research setting.
Methods
This systematic review was conducted in accordance with 
the Preferred Reporting Items for Systematic Review and 
Meta-Analyses (PRISMA) checklist [18]. The protocol was 
pre-registered in the International Prospective Register of 
Systematic Reviews (PROSPERO) and may be accessed 
under the registration number CRD 42020165496.
Literature search
The goal of the literature search was to identify any studies 
assessing DMDD. Therefore, a broad search strategy was 
formulated. The full electronic search strategy of the sys-
tematic literature search in the PubMed database (https:// 
pubmed. ncbi. nlm. nih. gov) was: ("Disruptive Mood Dysreg-
ulation*") OR ("DMDD"). No limits or filters were added 
to this search. PubMed, Embase, PsycINFO, and Web of 
Science databases were scrutinized for relevant literature 
published from 2013 to 31st March 2020. We used identical 
search terms in all databases. Further, reference lists of pub-
lications identified through database search were screened 
for potentially pertinent studies not identified in the ini-
tial search. To reflect the broadest use of tools to diagnose 
DMDD, in research as well as in the clinic, we included any 
regular article, case report, or conference abstract published 
in any of the searched databases.
Study selection
Studies were excluded if they (a) did not include patients 
with diagnosed DMDD; or (b) a full text was not available. 
Prior to a full-text review, the titles, abstracts, and methods 
sections of the articles identified through database searches 
were screened for the eligibility criteria outlined above by 
two independent reviewers until consensus was reached.
Data extraction
A digital data extraction sheet was developed and refined 
during the data extraction process. The following data were 
extracted if available: general information and identifying 
features of the study, i.e., full reference, year of publica-
tion, and country of study origin. Additionally, the article 
type was identified, comprising regular articles, conference 
abstracts, or case reports. All article types were included 
to cover the full breadth of tools available for research and 
clinical purposes. Magnitudes and percentages of all out-
come variables were given for all study types included as 
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well as for abstracts only. Further data extracted comprised 
details on the study design, study population, sample size, 
and age range. The main outcome was the tool used to diag-
nose DMDD, including the rater (clinician, parent, self) and 
whether psychometric properties had been assessed. Where 
possible, information about the number of items, adminis-
tration time, and availability of the tool (licensed vs. free of 
cost) in different languages was obtained. Authors were con-
tacted to provide details if any of the information of interest 
was not provided in the study.
Results
Search results
The first literature search, conducted on January 22, 2020, 
yielded K = 1149 records (PubMed k = 168, PsycINFO 
k = 471, Web of Science k = 201, Embase k = 309). Search 
updates identical to the first search were carried out on May 
26, 2020, yielding an additional k = 18 records. K = 351 
duplicates were removed from the K = 1167 records screened 
for eligibility. Of the k = 172 full-text articles screened for 
eligibility, a further k = 53 studies were excluded as they 
did not include patients with diagnosed DMDD and k = 9 
because a full text was not obtainable. The PRISMA flow 
diagram of the full process of study selection is depicted in 
Fig. 1.
Included studies
From the initial base of records, k = 110 studies fulfilled all 
inclusion criteria and were retained for qualitative syntheses.
General study characteristics of the included studies are 
described in Table 1. Of the included studies, k = 58 were 
regular articles (52.7%), while there were k = 41 conference 
abstracts (37.3%) and k = 11 case reports (10.0%). Most of 
the studies included a clinical sample (k = 83, 75.5%; k = 36 
abstracts, 32.7%), some were population-based (k = 12, 
10.9%; k = 2 abstracts, 1.8%), case studies (k = 11, 10.0%; 
k = 0 abstracts), cohort studies (k = 3, 2.7%; k = 1 abstract, 
0.9%) and k = 1 study was among youth in the juvenile jus-
tice setting (0.9%; k = 0 abstracts). K = 85 studies included 
unique samples (77.3%; k = 30 abstracts), while k = 25 arti-
cles (22.7%; k = 11 abstracts) reported data from overlap-
ping samples (see Table 1 for details). K = 86 studies were 
Fig. 1   PRISMA flow diagram 
depicting the study selection 
process
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Table 1  Study characteristics by year of publication
Authors Year Country of 
origin
Article type Study type Study design Sample N (% female) Age (range)5
Copeland et al. 
[10]
2013 USA Regular article Population-
based
Prospective Community 3258 (50) 2–17
Copeland et al. 
[11]
2014 USA Regular article Population-
based
Prospective2 Population 1420 (47) 10–25
Dougherty et al. 
[54]
2014 USA Regular article Population-
based
Prospective Community 462 (46) 6
Parmar et al. 
[55]
2014 USA Case report Case study Retrospective Outpatients 1 (0) 15
Roy et al. [43] 2014 USA Case report Case study Retrospective Outpatients 1 (0) 8
Sparks et al. 
[56]






2015 USA Regular article Clinical Prospective2 Outpatients 194 (35) 7–17
Estrada Prat 
et al. [58]
2015 Spain Conference 
abstract
Clinical Prospective Outpatients 8 (25) 7–18
Mitchell et al.a 
[59]
2015 Canada Conference 
abstract
Clinical Prospective Outpatients 116 (NA) NA
Schilpzand 
et al.b [60]
2015 Australia Conference 
abstract
Clinical Prospective patients 179 (31) 6–8
Stoddard et al. 
[61]
2015 USA Conference 
abstract




Tseng et al. [62] 2015 USA Conference 
abstract








Uran et al.c [64] 2015 Turkey Conference 
abstract




Althoff et al. [9] 2016 USA Regular article Population-
based
Prospective Population 6483 (51) 13–18
Averna et al. 
[65]
2016 Italy Case report Case study Retrospective Outpatient 1 (0) 11
Baweja et al. 
[66]
2016 USA Regular article Clinical Prospective2 Outpatients 38 (28) 7–12
Brotman et al. 
[67]
2016 USA Conference 
abstract






2016 USA Conference 
abstract
Clinical Prospective Community 36 (56) 6, 9 and 12
Copeland et al. 
[37]
2016 USA Conference 
abstract
Clinical Prospective2 Community 112 (NA) M 11.4
Dougherty 
et al.d [69]
2016 USA Regular article Population-
based
Prospective Population 473 (46) 3 6 and 9
Freeman et al. 
[70]
2016 USA Regular article Clinical Prospective2 Outpatients 597 (39) 6–18
Fristad et al. 
[71]
2016 USA Regular article Clinical Prospective Patients 217 (38) 6–12
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Table 1  (continued)
Authors Year Country of 
origin
Article type Study type Study design Sample N (% female) Age (range)5
Kessel et al. 
[39]
2016 USA Regular article Population-
based
Prospective Community 373 (45) 9
Kilic et al. [73] 2016 Turkey Case report Case study Retrospective Outpatient 1 (0) 18
Mitchell et al.a 
[74]
2016 Canada Regular article Clinical Prospective Outpatients 108 (68) 13–19
Mulraney et al.b 
[75]
2016 Australia Regular article Clinical Prospective Community 179 (25) 6–8
Pogge et al. [76] 2016 USA Conference 
abstract
Clinical Prospective Inpatients 100 (NA) 6–12
Stoddard et al. 
[77]




Stoddarde [78] 2016 USA Conference 
abstract






2016 Turkey Conference 
abstract
Clinical Prospective Outpatients 29 (NA) M 9.2
Tiwari et al. 
[80]
2016 India Regular article Clinical Prospective Inpatients 70 (24) 6–16
Topal et al.f [81] 2016 Turkey Conference 
abstract
Clinical Prospective Outpatients 90 (48) 12–16
Topal et al.f [82] 2016 Turkey Conference 
abstract




Tudor et al. [83] 2016 USA Case report Case study Retrospective Patients 1 (100) 9
Tufan et al. [84] 2016 Turkey Regular article Clinical Retrospective Outpatients 403 (NA) 6–17
Wiggins et al. 
[41]










Prospective Population 500 (NA) 5–21
Dougherty 
et al.d [86]
2017 USA Regular article Clinical Prospective Community 329 (51) 6 and 9
Estrada Prat 
et al. [87]
2017 Spain Regular article Clinical Prospective Patients 35 (33) 6–18
Eyre et al.g [88] 2017 UK Regular article Clinical Prospective Patients 696 (16) 6–18
Faheem et al. 
[89]
2017 USA Regular article Clinical Retrospective Inpatients 490 (NA) 6–18
Higdon et al. 
[90]
2017 USA Conference 
abstract
Clinical Prospective Overweight 
patients
438 (52) 7–19
Jain [91] 2017 India Conference 
abstract
Clinical Prospective Patients 25 (12) 6–9
Jalnapurkar 
et al. [92]
2017 USA Conference 
abstract
Clinical Prospective Inpatients 95 (NA) 8–17
Kircanski et al.h 
[93]
2017 USA Conference 
abstract
Clinical Prospective Outpatients 197 (46) 8–18
Kircanski et al.h 
[94]
2017 USA Conference 
abstract




Le et al. [95] 2017 USA Conference 
abstract
Clinical Retrospective Patients 7268 (NA)  < 18
Martin et al. 
[96]
2017 USA Regular article Clinical Prospective Outpatients 139 (25) 4–5
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Table 1  (continued)
Authors Year Country of 
origin
Article type Study type Study design Sample N (% female) Age (range)5
Matthews et al. 
[97]
2017 USA Conference 
abstract





2017 USA Case report Case study Prospective Outpatient 1 (100) 9
Mitchell et al. 
[98]
2017 Australia Conference 
abstract
Clinical Prospective Youth at famil-










2017 Turkey Regular article Clinical Retrospective Outpatients 12 (0) 8–17
Pagliaccio et al. 
[101]











2017 USA Conference 
abstract












2017 Brazil Case report Case study Retrospective Outpatients 1 (0) 7
Stoddard et al.e 
[106]
2017 USA Regular article Clinical Prospective patients 115 (44) 8–17
Stoddard et al. 
[107]
2017 USA Conference 
abstract






2017 USA Conference 
abstract






2017 Turkey Conference 
abstract
Clinical Prospective Patients and 
healthy con-
trols
43 (NA) M 9.5
Taskiran et al.j 
[110]
2017 Turkey Conference 
abstract






2017 USA Conference 
abstract






2017 USA Conference 
abstract
Clinical Retrospective Outpatients 56 (29) 7–12
Abouzed et al. 
[113]
2018 Egypt Conference 
abstract








2018 USA Conference 
abstract
Clinical Retrospective Patients 360 (29) 4–17
Cuffe et al. 
[115]







de la Peña et al. 
[38]
2018 Latin  America1 Regular article Clinical Prospective Outpatients 80 (40) 6–18
Delaplace et al. 
[116]
2018 France Regular article Clinical Prospective Outpatients 21 (10) 9–15
European Child & Adolescent Psychiatry 
1 3
Table 1  (continued)
Authors Year Country of 
origin
Article type Study type Study design Sample N (% female) Age (range)5
Fridson et al. 
[117]
2018 USA Conference 
abstract
Clinical Retrospective Patients 839 (NA) 6–18
Grau et al. [36] 2018 Germany Regular article Population-
based
Prospective Population 2413 (NA) 18–94
Kircanski et al.h 
[118]
2018 USA Regular article Clinical Prospective Community 197 (46) 8–18
Miller et al. 
[119]
2018 USA Regular article Clinical Prospective outpatients 19 (42) 12–17
Mroczkowski 
et al. [120]




Pan et al. [121] 2018 Taiwan Regular article Clinical Prospective Outpatients 58 (17) 7–17
Sagar-Ouriaghli 
et al. [122]
2018 Great Britain Regular article Clinical Prospective2 Outpatients 117 (NA) 6–12
Vidal-Ribas 
et al. [123]






2018 USA Conference 
abstract
Clinical Retrospective Outpatients 1088 (46) NA
Wiggins et al. 
[125]
2018 USA Regular article Clinical Prospective Outpatients 425 (51) 3–5
Winters et al. 
[126]
2018 USA Regular article Clinical Prospective Patients 22 (31) 9–15
Basu et al. [127] 2019 Australia Regular article Clinical Retrospective Patients 101 (58) 6–12
Benarous et al. 
[128]
2019 France Case report Case study Retrospective Inpatients 6 (30) 10–14
Benarous et al. 
[129]
2019 France Conference 
abstract
Clinical Retrospective Outpatients 163 (40) 7–17
Chen et al. [130] 2019 Taiwan Regular article Population-
based
Prospective Population 4816 (48) 10–17
Eyre et al.g 
[131]
2019 UK Regular article Clinical Prospective Patients 696 (16) 6–18
Guilé [132] 2019 France Conference 
abstract
Clinical Prospective Patients and 
healthy con-
trols
21 (100) M 11.7  ± 3 SD
Haller et al. 
[133]
2019 USA Conference 
abstract






2019 USA Case report Case study Retrospective Outpatient 1 (0) 14
Linke et al. 
[135]
2019 USA Case report Case study Retrospective Outpatient 1 (0) 11
Linke et al. 
[136]






2019 Australia Conference 
abstract
Cohort study Prospective Patients 134 (28) 7–10
Rice et al. [138] 2019 USA Case report Case study Retrospective Inpatient 1 (100) 12
Towbin et al. 
[139]
2019 USA Regular article Clinical Prospective Patients 53 (36) 7–17
Tseng et al.k 
[140]






2019 Turkey Regular article Population-
based
Prospective Community 356 (55) 6–11
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conducted prospectively (78.2%; k = 35 abstracts, 31.8%) 
and k = 24 retrospectively (21.8%; k = 7 abstracts, 6.4%). 
Among the prospective studies, k = 7 assessed DMDD ret-
rospectively (6.4%; k = 1 abstracts, 0.9%).
There was an initial increase in numbers of publications 
from 2013 until 2017, after which numbers dropped again: 
k = 1 study in 2013 (0.9%; k = 0 abstracts), k = 5 in 2014 
(4.5%; k = 0 abstracts), k = 8 in 2015 (7.3%; k = 6 abstracts, 
5.5%), k = 24 in 2016 (21.8%; k = 7 abstracts, 6.4%), k = 29 
in 2017 (26.4%; k = 16 abstracts, 14.5%), k = 16 in 2018 
(14.5%; k = 5 abstracts, 4.5%), and k = 16 in 2019 (14.5%; 
k = 4 abstracts, 3.6%) and k = 11 in 2020 (10.0%; k = 2 
abstracts, 1.8%).
Most of the included studies stem from the United States 
of America (k = 66, 60.0%; k = 26 abstracts, 23.6%). Other 
countries of origin include Turkey (k = 12, 10.9%; k = 6 
Table 1  (continued)
Authors Year Country of 
origin
Article type Study type Study design Sample N (% female) Age (range)5
Ünal et al. [40] 2010 Turkey Regular article Clinical Prospective Outpatients 120 (49) 6–17
Alexander et al. 
[27]
2020 USA Regular article Clinical Prospective Community 523 (41) 6–17
Benarous et al. 
[142]





Regular article Clinical Retrospective outpatients 163 (43) 7–27
Chang et al. 
[144]
2020 Taiwan Regular article Clinical Prospective Patients 101 (31) 7–18
Cimino et al. 
[145]






2020 USA Conference 
abstract
Clinical Prospective Patients 189 (34) M 13.1
Haller et al. 
[147]
2020 USA Regular article Clinical Prospective Patients 98 (41) 7–17
Johnstone et al. 
[148]
2020 USA Regular article Clinical Retrospective Patients 168 (23) 6–12
Laporte et al.i 
[45]
2020 Brazil Regular article Cohort study Prospective Birth cohort 
(Pelotas study)
3562 (NA) 10–12
Le et al. [149] 2020 USA Regular article Population-
based
Retrospective Patients covered 
by Medicaid
814,919 (49)  < 18
Tseng et al. 
[150]
2020 USA Conference 
abstract
Clinical Prospective Patients 69 (NA) M 14.5
DMDD disruptive mood dysregulation disorder, ADHD attention deficit hyperactivity disorder, ODD oppositional defiant disorder, BD bipolar 
disorder, SMD severe mood dysregulation, MDD major depressive disorder. NA information not available
a Mitchell et al. (2015) and (2016) report data from overlapping samples
b Schipzand et al. (2015) and Mulraney et al. (2016) report data from overlapping samples
c Uran et al. (2015) abstract and regular article report on same data
d Dougherty et al. (2016) and (2017) partly report on overlapping data
e Stoddard et al. (2016) and (2017) report on overlapping data
f Topal et al. (2016) abstracts report data from overlapping samples
g Eyre et al. (2017) and (2019) report on overlapping data
h Kircanski et al. (2017) and (2018) report on overlapping data
i Munhoz et al. (2017) and Laporte et al. (2020) report on overlapping data
j Taskiran et al. (2017) abstracts report on overlapping data
k Tseng et al. (2017) and (2019) report on overlapping data
1 Mexico, Colombia, Chile, and Uruguay
2 DMDD diagnosis was obtained retrospectively
3 Where not otherwise specified, patients were in- and outpatients
4 Experiment 1
5 Mean (M) is given, where no information about range was available
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abstracts, 5.5%), France (k = 6, 5.5%; k = 2 abstracts, 1.8%), 
Australia (k = 5, 4.5%; k = 3 abstracts, 2.7%), Brazil (k = 3, 
2.7%; k = 0 abstracts), Canada (k = 3, 2.7%; k = 1 abstracts), 
United Kingdom (k = 3, 2.7%; k = 0 abstracts), Taiwan (k = 3, 
2.7%; k = 0 abstracts), India (k = 2, 1.8%; k = 1 abstract), 
Spain (k = 2, 1.8%; k = 1 abstract), Italy (k = 2, 1.8%; k = 0 
abstracts), Egypt (k = 1, 0.9%; k = 1 abstract) and Germany 
(k = 1, 0.9%; k = 0 abstracts). K = 1 regular article includes 
data from Mexico, Colombia, Chile, and Uruguay (0.9%).
Most study samples consisted of patients (in- and/or 
outpatients) k = 85 (77.3%; k = 33 abstracts, 30.0%). Of 
those, some reported to include only outpatients (n = 39, 
35.5%; k = 10 abstracts, 9.1%), or inpatients (n = 7, 6.4%; 
k = 3 abstracts, 2.7%). Further, study samples consisted of 
community (n = 10, 9.1%; k = 2 abstracts, 1.8%), popula-
tion (n = 7, 6.4%; k = 2 abstracts, 1.8%), youth at familial 
risk of psychiatric disorders (n = 4, 3.6%; k = 3 abstracts, 
2.7%) birth cohorts (n = 2, 1.8%; k = 0 abstracts), juvenile 
justice involved youths (n = 1, 0.9%; k = 0 abstracts), and 
overweight patients (n = 1, 0.9%, k = 1 abstract). Many of 
the studies further examined healthy controls in addition to 
a patient group (n = 26, 23.6%). Sample sizes ranged from 
k = 1 in case-reports to k = 6483 in a large population-based 
study. Examined ages lay between 2 and 94 years of age, 
while most samples’ ages ranged from early school-age to 
adolescence or young adulthood.
Measurement of DMDD diagnosis
A variety of instruments were used to diagnose DMDD in 
the included studies. The instrument used most often was 
the Kiddie Schedule for Affective Disorders and Schizo-
phrenia Present and Lifetime Version, K-SADS-PL [19] 
(n = 48, 43.6%; k = 20 abstracts, 18.2%) in combination 
with the DMDD module (Table 2), k = 27 (24.5%; k = 12 
abstracts, 10.9%). The Preschool Age Psychiatric Assess-
ment, PAPA [20] was used in k = 7 studies (6.4%; k = 1 
abstracts, 0.9%), of which k = 4 did so in combination with 
ODD and depression sections. In k = 3 (2.7%) studies each, 
the Child and Adolescent Psychiatric Assessment, CAPA 
[21] (n = 0 abstracts), the Diagnostic Interview Schedule for 
Children, Version IV, DISC-IV [22] (n = 1 abstract, 0.9%), 
and the Washington University in St. Louis Kiddie Schedule 
for Affective Disorders and Schizophrenia, WASH-U-K-
SADS [23] (n = 1 abstract, 0.9%) were used. In k = 2 stud-
ies (1.8%) each, the Breton, Bergeron and Labelle DMDD 
Scale [24] (n = 1 abstract, 0.9%), the Conners rating scales 
[25] (n = 1 abstract, 0.9%), the Development and Well-Being 
Assessment, DAWBA [26] and the Extended Strengths and 
Weaknesses Assessment of Normal Behavior, E‐SWAN [27] 
(n = 1 abstracts, 0.9%) were used. Instruments used in k = 1 
(0.9%) regular articles each included the Child and Ado-
lescent Symptom Inventory, CASI [28], the Child Behavior 
Check List dysregulation profile, CBCL-DP [29], the Chil-
dren’s Interview for Psychiatric Syndromes, ChIPS [30] in 
combination with the Mini-International Neuropsychiatric 
Interview for Children and Adolescents, MINI-KID [31], the 
Composite International Diagnostic Interview CIDI [32], 
the Diagnostic Infant and Preschool Assessment, DIPA [33], 
the Mandarin Version of the K-SADS-Epidemiological Ver-
sion for DSM-5, K-SADS-E [34], the Structured Clinical 
Interview for DSM-IV, SCID-IV [35], a self-created set 
of six questions [36], and the Voice Diagnostic Interview 
Schedule for Children, V-DISC [22]. A not otherwise speci-
fied structured interview was reported in k = 1 conference 
abstract [37].
In k = 8 studies (7.3%; k = 2 abstracts, 1.8%) a clinical 
diagnosis was made without any specific measures and in 
k = 7 studies (6.4%; k = 3 abstracts, 2.7%) diagnosis was 
made using chart review or Medicaid records (n = 1). Finally, 
k = 10 (9.1%; k = 6 abstracts, 5.5%) studies did not provide 
any information on the measure used.
In most of the measures used in the included studies, a 
clinician rated the patients’ and participants’ statements and 
behavior (n = 91, 82.7%), while others consisted of a parent- 
(n = 3, 2.7%), or self-rating (n = 4, 3.6%). No information 
about the rater was given in k = 10 (9.1%) studies.
Psychometric properties
In k = 79 studies (71.8%; k = 17 abstracts, 15.5%), any infor-
mation on the presence or absence of psychometric prop-
erties of the measure used to diagnose DMDD was given 
or obtained from the authors. Of those, in k = 39 (35.5%; 
k = 4 abstracts, 3.6%) no psychometric properties have been 
obtained or reported as part of the study or using the study 
data. In the remaining k = 40 studies (36.4%, k = 13 abstracts, 
11.8%), the most commonly reported psychometric property 
was reliability, with k = 33 (30.0%; k = 13 abstracts, 11.8%) 
reporting inter-rater reliability ranging from κ = 0.6 to 1 
and k = 29 (26.4%; k = 11 abstracts, 10.0%) reporting intra-
class correlation coefficients. Three studies assessed inter-
nal consistency with Cronbach’s alpha = 0.92 for a Spanish 
version of the K-SADS-PL modified under the DSM-5 to 
diagnose DMDD [38], and Cronbach’s alpha = 0.75 for the 
PAPA [39] and 0.98 for the E-SWAN DMDD scale [27]. In 
the studies of the NIMH group around Dr. Ellen Leibenluft 
(n = 25, 22.7%), raters were trained to reach inter-rater reli-
ability with κ ≥ 0.9, before they contributed to interviews/
data collection for the respective studies. Cases were further 
discussed in conference with other reliable clinicians and 
in a lab meeting where leading clinicians reviewed the core 
criteria before diagnosis was made. The same group also 
provided ICCs ≥ 0.9 differentiating the DMDD module from 
the mania/hypomania part of the K-SADS-PL. One study 
examined consensus validity between a clinical psychiatric 
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interview based on DSM-5 diagnostic criteria and the 
Turkish version of the DSM-5 version of the K-SADS-PL 
(K-SADS-PL-DSM-5-T), led by two independent clinician-
researchers [40]. A consensus of 96%, κ = 0.63 was reached. 
Further, concurrent validity was evaluated with the Affec-
tive Reactivity Index (ARI), κ = 0.70. One study generated 
Receiver Operating Characteristic (ROC) curves to obtain 
Area Under the Curve (AUC) for their diagnostic instrument, 
as a measure of predictive validity. With an AUC value of 
0.85, the E-SWAN DMDD scale performed equally well in 
predicting diagnoses compared to the Affective Reactivity 
Index [27].
Discussion
Evidence from this systematic review points to a variety 
of different measures used for the evaluation and diagno-
sis of DMDD. The majority of studies used clinician-rated 
structured interviews in combination with DMDD specific 
symptom checklists. Few studies employed questionnaires 
or interviews specifically designed to measure DMDD or its 
severity. In the following, some of the most used measures 
are presented in more detail, before practical aspects, such as 
available languages and cost as well as diagnostic challenges 
and future directions are discussed.
By far the most often used instrument was the K-SADS-
PL in combination with the DMDD module. The K-SADS-
PL is a semi-structured interview to diagnose mental disor-
ders in children aged 6–18. Administration time is estimated 
to be about 75 min for psychiatric patients and 35–45 min 
for healthy control subjects. It is freely available for down-
load online. It has high inter-rater reliability and good to 
excellent test–retest reliability [19]. The DMDD module has 
been developed by a workgroup around Leibenluft, in col-
laboration with the K-SADS developer Kaufman. A prior 
version of this module was based on a research diagnosis 
coined severe mood dysregulation (SMD) [4]. The DMDD 
module is a checklist consisting of four items probing for the 
DSM-5 criteria to be met (Fig. 2, see supplementary mate-
rial for the DSM-5 diagnostic criteria A-K). With training 
and case discussion, the module can be administered with 
high inter-rater reliability [41]. It has further shown to dif-
ferentiate well between other mood disorders such as mania/
hypomania.
Our study’s findings revealed different methodological 
approaches to diagnosing DMDD. Some of the instruments 
utilized in the reviewed studies consisted of a symptom 
checklist. This was the case not only for the K-SADS-PL 
DMDD module but also for its precursor, the SMD module 
or the ODD module. While the checklist format might sug-
gest simplicity, it is most often used in the context of the 
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which is used by raters to create a proxy diagnostic using 
a combination of ODD, depression, or mania criteria, and 
thereby empirically derive a DMDD diagnosis. Moreover, a 
combination of comprehensive structured or semi-structured 
interviews (e.g., K-SADS-PL, SCID, DISC or CIDI) and 
self-made checklists or clinical evaluation to probe for DSM 
criteria have been employed. An approach that has further 
been adopted in some of the reviewed studies was to search 
established interviews or questionnaires (CBCL-DP, Con-
ners, ChIPS, MINI or PAPA/CAPA/DIPA) for items relevant 
to the DMDD diagnosis. This approach likely stems from 
the fact that these studies assessed DMDD retrospectively in 
data not collected with the focus of determining the preva-
lence of DMDD.
Few instruments have been deliberately designed to diag-
nose DMDD. Those identified by this systematic review 
were the K-SADS-PL DMDD module, the Breton, Bergeron 
and Labelle DMDD scale (available as a semi-structured 
interview and questionnaire), the E-SWAN DMDD module 
(interview) and the DAWBA DMDD section (interview; see 
Table 3 for an overview of instruments designed to diag-
nose DMDD). The instruments contain 4–34 items assessing 
occurrences, frequencies, and circumstances of temper tan-
trums/outbursts and irritable or angry mood. All instruments 
are available in the English language. The Breton, Bergeron 
and Labelle DMDD Scale is additionally available in French, 
and the DAWBA DMDD section additionally exists in Dan-
ish and Portuguese. The E-SWAN and DAWBA scales are 
freely available online or upon request to the authors. Indi-
cated age ranges are similar, encompassing preschool age 
to early adulthood. While the K-SADS-PL DMDD module, 
the Breton, Bergeron and Labelle DMDD Scale, and the 
DAWBA DMDD section provide categorical outcomes, the 
E-SWAN DMDD module is designed to capture DMDD 
symptoms dimensionally. This scale reconceptualizes each 
diagnostic criterion for DMDD as a behavior, which can 
range from high (strengths) to low (weaknesses). Regard-
ing the psychometric properties, it seems that the DMDD 
module has been evaluated most often, as high levels of 
reliability are reported in many studies. However, these 
reliabilities have been reached artificially by training raters 
to differentiate K-SADS-PL DMDD from mania modules. 
Although useful for the clinic, this approach does not corre-
spond to the evaluation of reliability as a measure of consist-
ency between raters for a certain diagnostic instrument used 
in a study. Therefore, a more comprehensive psychometric 
evaluation of this widely used measure is necessary. Besides 
the DMDD module, psychometric properties have been 
reported for the E-SWAN DMDD module. The reliability 
of this scale has been reported to be excellent (Cronbach’s 
1. Criterion A-D have been present for 12 months or more, no period of three or more consecutive 
months without symptoms.
2. Criterion A-D are present in at least two of the three settings listed below:
       Specify: _______ Home _______ School _______ Peers
3. Onset of Criterion A-E before age of 10.
4. Evidence of Disruptive Mood Dysregulation Disorder
Fig. 2   K-SADS-PL DMDD module. Each of the questions are evalu-
ated with 0, 1 or 2 for current and/or past episodes. The diagnostic 
criteria of DMDD are listed below the questions in the module (see 
supplementary material for the DSM-5 diagnostic criteria). Reprint 
authorized by Joan Kaufman, owner of the copyright of the K-SADS-
PL
Table 3   Instruments designed to diagnose DMDD
DMDD disruptive mood dysregulation disorder, NA information not available








K-SADS-PL DMDD module Symptom Checklist 4 Yes English No 6–19




11 NA English, French No NA
DAWBA DMDD section Interview 34 Yes English, Danish, Portugese No 5–18
E-SWAN DMDD module Interview 10 Yes English Yes 6–17
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alpha = 0.98). Reporting of psychometric properties of the 
other DMDD scales is still pending. Studies using tools to 
diagnose DMDD followed a broad spectrum of study objec-
tives and hypotheses. Thus, the DMDD measure and its 
psychometric properties might not have been the focus of 
attention, which might be the reason for not providing this 
information. However, to determine gold-standard measure-
ment, psychometric evaluation of the currently used diag-
nostic measures is necessary.
When assessing the psychometric properties of the instru-
ments used in the included studies, mainly measures of reli-
ability have been considered and reported. However, the 
psychometric evaluation of a diagnostic tool ideally also 
contains the assessment of its validity. Neither content-
related (e.g., construct validity, factorial structure) nor 
criterion-related types of validity (e.g., concurrent or pre-
dictive validity) have been considered broadly in existing 
studies. One study reported substantial consensus validity 
(κ = 0.63) and concurrent validity (κ = 0.70) of a Turkish 
version of the K-SADS-PL [40]. A further study showed 
substantial predictive validity of the E-SWAN DMDD mod-
ule (AUC = 0.85) [27]. Consequently, measures of validity 
require more attention in future research on the measure-
ment of DMDD and should guide the reporting of respective 
measures in future studies.
Given the aim of the present systematic review, to provide 
an overview of existing instruments for the assessment of 
DMDD and their use in the diagnostic process, we refrained 
from conducting a formal risk of bias assessment of included 
studies. The potential risk of bias does not interfere with the 
aim of the present review and was thus deemed irrelevant.
Since the advent of DMDD, clinicians and research-
ers have noted various challenges and the diagnosis is not 
without controversy [17]. The characteristic symptoms of 
DMDD, namely irritable mood and temper outbursts are 
observed across multiple disruptive behavior and mood dis-
orders and the validity of DMDD as a distinct diagnosis has 
been questioned [13, 42, 43]. Further, DMDD could not be 
distinguished from ODD based on symptomatology alone in 
a population-based study [44]. It has further been criticized 
that alternative thresholds for defining DMDD, as well as a 
closer investigation of clinically relevant thresholds, have 
so far only partly been considered in the existing literature 
[45]. The lack of precision in diagnosing DMDD might in 
part account for the criticism voiced about the clinical entity 
of DMDD. Similarly, the heterogeneity in measurement of 
DMDD up to date, as found in the present systematic review 
of the literature, might account for variations in current prev-
alence and comorbidity rates as well as findings on associa-
tions with risk factors or functional outcomes in individuals 
with DMDD. Studies designed a priori with appropriate 
instruments to capture DMDD are therefore necessary [46].
While the diagnostic entity of DMDD may be a useful 
clinical heuristic, many researcher-clinicians focus their 
efforts on broader transdiagnostic constructs, such as irrita-
bility [8]. Irritability has been defined as a heightened prone-
ness to anger relative to peers [47, 48] which can be seen 
as a personality trait with a continuous distribution across 
the population. In children and adolescents with DMDD, by 
definition, irritability is severe and expressed stably across 
time. In the last decade, there has been a marked increase 
in irritability research and there have been neuroscientific 
as well as treatment-related approaches to understanding 
pathophysiological mechanisms [41, 49]. Until now, whether 
persistent irritability between temper outbursts and the out-
bursts themselves are independent of each other, or whether 
the mood between outbursts is rather a concatenation of less 
severe tantrums, remains unknown.
In addition to further psychometric evaluation of current 
diagnostic measures and the development of a gold-stand-
ard diagnostic measure, adjuvant measurement approaches 
have become popular in the last decade. One promising 
approach to describe the full spectrum of irritability and 
temper outbursts in patients’ everyday lives is ecological 
momentary assessment (EMA; also known as experience 
sampling method or ambulatory assessment). This involves 
the repeated sampling of patients’ experiences or mood, per-
formed via a handheld device such as a mobile phone. This 
measurement method has high ecological validity, avoiding 
biases due to retrospective assessments [50]. The repeated 
measurement of affect, with multiple measurements during 
the day over several days, potentially in children or their 
parents might be insightful in the characterization of hourly 
and daily fluctuations of mood in patients with irritability 
and/or DMDD.
To inform the debate around the diagnostic entity of 
DMDD, the application of Research Domain Criteria 
(RDoC) constructs may yield greater clarity in terms of 
underlying processes and thus inform nosology as well as 
appropriate interventions [51]. The constructs of frustrative 
non-reward (Negative Valence Domain), reward prediction 
error (Positive Valence domain), attention and language 
(Cognitive domain) as well as arousal (Arousal and Regula-
tory systems) have been found to be particularly promising 
in this regard.
Limitations of the review
The present systematic review encompasses literature involv-
ing instruments for the categorical diagnosis of DMDD. In 
view of the described developments regarding dimensional 
aspects of DMDD, a systematic review of the literature on 
dimensional constructs, such as irritability would be inform-
ative and topical. Similarly, a comprehensive overview on 
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the examination of developmentally non-appropriate temper 
tantrums would be of interest in this regard.
A substantial proportion of the studies included in this 
systematic review stems from one laboratory in the United 
States. More studies evaluating the reliability and validity 
of the DMDD diagnosis should be conducted in other labo-
ratories, to reduce the potential bias of findings and address 
cultural differences.
Psychological assessment should not be made based on 
any one instrument in isolation. Rather, test findings should 
be integrated with information from personal and educa-
tional histories and in collaboration with other clinicians 
[52, 53]. Consequently, using any current instruments to 
evaluate DMDD will require additional query and clinical 
evaluation. For research purposes, however, standardized 
assessment methods are inevitable.
Conclusion and future directions
A variety of different measures have been used for the evalu-
ation of DMDD. The most commonly used and established 
instrument consists of a symptom checklist, while more 
recently developed structured interviews and questionnaires 
are still to establish their reliability and validity in diagnos-
ing DMDD. Dimensional and experimental approaches to 
assessing irritability and temper outbursts as well as their 
interrelation might bring forth more clarity about DMDD 
symptomatology in children.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s00787- 021- 01840-4.
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